Prehosp Emerg Care. 2019 Nov-Dec;23(6):820-827. doi: 10.1080/10903127.2019.1587126. Epub 2019 Mar 27.
Severe traumatic brain injury (TBI) is associated with a high mortality rate and those that survive commonly have permanent disability. While there is a broad consensus that appropriate prehospital treatment is crucial for a favorable neurological outcome, evidence to support currently applied treatment strategies is scarce. In particular, the relationship between prehospital treatments and patient outcomes is unclear. The BRAIN-PROTECT study therefore aims to identify prehospital treatment strategies associated with beneficial or detrimental outcomes. Here, we present the study protocol. BRAIN-PROTECT is the acronym for in jury: rehospital egistry of utcome, reatments and pidemiology of erebral rauma. It is a prospective observational study on the prehospital treatment of patients with suspected severe TBI in the Netherlands. Prehospital epidemiology, interventions, medication strategies, and nonmedical factors that may affect outcome are studied. Multivariable regression based modeling will be used to identify confounder-adjusted relationships between these factors and patient outcomes, including mortality at 30 days (primary outcome) or mortality and functional neurological outcome at 1 year (secondary outcomes). Patients in whom severe TBI is suspected during prehospital treatment (Glasgow Coma Scale score ≤ 8 in combination with a trauma mechanism or clinical findings suggestive of head injury) are identified by all four helicopter emergency medical services (HEMS) in the Netherlands. Patients are prospectively followed up in 9 participating trauma centers for up to one year. The manuscript reports in detail the objectives, setting, study design, patient inclusion, and data collection process. Ethical and juridical aspects, statistical considerations, as well as limitations of the study design are discussed. Current prehospital treatment of patients with suspected severe TBI is based on marginal evidence, and optimal treatment is basically unknown. The BRAIN-PROTECT study provides an opportunity to evaluate and compare different treatment strategies with respect to patient outcomes. To our knowledge, this study project is the first large-scale prospective prehospital registry of patients with severe TBI that also collects long-term follow-up data and may provide the best available evidence at this time to give useful insights on how prehospital care can be improved.
严重创伤性脑损伤(TBI)死亡率高,幸存者通常有永久性残疾。尽管人们广泛认为适当的院前治疗对于良好的神经预后至关重要,但支持当前应用的治疗策略的证据很少。特别是,院前治疗与患者结局之间的关系尚不清楚。因此,BRAIN-PROTECT 研究旨在确定与有益或有害结局相关的院前治疗策略。在这里,我们介绍研究方案。BRAIN-PROTECT 是损伤:再入院结局、创伤性脑损伤的治疗和流行病学的缩写。这是一项在荷兰对疑似严重 TBI 患者进行院前治疗的前瞻性观察研究。研究了院前流行病学、干预措施、药物治疗策略以及可能影响结局的非医学因素。多变量回归建模将用于确定这些因素与患者结局之间存在混杂因素调整的关系,包括 30 天死亡率(主要结局)或 1 年死亡率和功能神经结局(次要结局)。在院前治疗期间怀疑患有严重 TBI 的患者(格拉斯哥昏迷量表评分≤8 分,同时伴有创伤机制或临床发现提示头部受伤)由荷兰的所有 4 个直升机紧急医疗服务(HEMS)识别。患者在 9 个参与的创伤中心进行前瞻性随访,最长可达 1 年。该手稿详细报告了研究的目的、背景、研究设计、患者纳入和数据收集过程。讨论了伦理和法律方面、统计考虑因素以及研究设计的局限性。目前对疑似严重 TBI 患者的院前治疗基于有限的证据,基本不知道最佳治疗方法。BRAIN-PROTECT 研究提供了一个机会,可以评估和比较不同的治疗策略对患者结局的影响。据我们所知,该研究项目是第一个对严重 TBI 患者进行大规模前瞻性院前登记的研究项目,该项目还收集了长期随访数据,目前可能提供最佳可用证据,为如何改进院前护理提供有用的见解。